E-6837 is an orally active, 5-HT₆ agonist developed in an attempt to create an anti-obesity medication. In cell lines expressing rat 5-HT₆ receptors, it acted as a partial agonist, while it acted as a full agonist on human 5-HT₆ receptors. Oral... Wikipedia